产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 25mg | 97% | 现货 | |||
| 100mg | 97% | 现货 | |||
| 250mg | 97% | 现货 | |||
| 500mg | 97% | 现货 | |||
| 1g | 97% | 现货 | |||
| 5g | 97% | 现货 | |||
| 10g | 97% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 25mg | 97% | 现货 | |||
| 100mg | 97% | 现货 | |||
| 250mg | 97% | 现货 | |||
| 500mg | 97% | 现货 | |||
| 1g | 97% | 现货 | |||
| 5g | 97% | 现货 | |||
| 10g | 97% | 现货 |
CAS No. |
118949-63-6 |
|---|---|
中文名称 |
2,6-二[(4S)-4-叔丁基-2-噁唑啉基基]吡啶 |
英文名称 |
2,6-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine |
别名 |
118949-63-6 | 2,6-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine | 2,6-BIS[(4S)-4-TERT-BUTYL-2-OXAZOLIN-2YL]PYRIDINE | (4S)-4-tert-butyl-2-[6-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridin-2-yl]-4,5-dihydro-1,3-oxazole | 2,6-BIS[(4S)-4-TERT-BUTYLO |
标准英文名 |
2,6-bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine |
MDL No. |
- |
分子式 |
C19H27N3O2 |
分子量 |
329.44 |
精确分子量 |
329.21 |
SMILES |
CC(C)(C)[C@H]1COC(=N1)C1=CC=CC(=N1)C1=N[C@H](CO1)C(C)(C)C |
标准SMILES |
CC(C)(C)[C@H]1COC(=N1)C1=CC=CC(=N1)C1=N[C@H](CO1)C(C)(C)C |
性状 |
White to light-gray powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
UBWMXPSQXYYPJG-HUUCEWRRSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
手性 |
Consistent with structure |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A ),Specific target organ toxicity, single exposure;Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|